Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
500 participants
INTERVENTIONAL
2024-02-07
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of "Medisinstart"
NCT02261402
Implementation of a New Model of Care for Supporting Long-term Medication Adherence (Phase A)
NCT06191835
Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland
NCT07036471
Effect of Pharmacist Provided Drug Information Services After Hospital Discharge
NCT03829995
Vascular Lifestyle-Intervention and Screening in Pharmacy
NCT02223793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medisinstart
Medisinstart
Medisinstart is a counseling service in pharmacies where patients who start taking a new medicine receive two follow-up consultations with a pharmacist.
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medisinstart
Medisinstart is a counseling service in pharmacies where patients who start taking a new medicine receive two follow-up consultations with a pharmacist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* The drugs are administered by the patient/relatives
* Good command of Norwegian, both written and spoken
Exclusion Criteria
* Not able to attend physical appointments in the pharmacy
* Not given written consent to participate in the study
* Diabetes medication is administered by a healthcare professional
* Known pregnancy
* HbA1c is unsuitable as an average measure of blood glucose at baseline
* Received initiation of medication for type 2 diabetes within the last year
* Ongoing participation in other studies involving similar interventions to increase adherence and ensure correct medication use
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Pharmacy Association
OTHER
Apokus AS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sara Bremer, PhD
Role: PRINCIPAL_INVESTIGATOR
Head of Research and Development
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ryfylke apotek
Rennesøy, Rennesøy, Norway
Apotek 1 Veakrossen
Veavåg, Veavåg, Norway
Vitusapotek Åfjord
Åfjord, , Norway
Apotek 1 Andslimoen
Bardufoss, , Norway
Apotek 1 Brandbu
Brandbu, , Norway
Apotek 1 Brummundal
Brumunddal, , Norway
Sykehusapoteket i Drammen
Drammen, , Norway
Vitusapotek Gjøvik
Gjøvik, , Norway
Vitusapotek Jessheim
Jessheim, , Norway
Boots apotek Kløfta
Kløfta, , Norway
Vitusapotek Leksvik
Leksvik, , Norway
Apotek 1 Lena
Lena, , Norway
Boots apotek Loddefjord
Loddefjord, , Norway
Sykehusapoteket i Oslo, Aker
Oslo, , Norway
Vitusapotek Røa
Oslo, , Norway
Vitusapotek Jekta
Tromsø, , Norway
Sykehusapoteket i Trondheim
Trondheim, , Norway
Vitusapotek Ulefoss
Ulefoss, , Norway
Boots apotek Linnea
Øystese, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Apokus-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.